GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Olympus Corp (TSE:7733) » Definitions » Net Income

Olympus (TSE:7733) Net Income : 円270,427 Mil (TTM As of Dec. 2023)


View and export this data going back to 1949. Start your Free Trial

What is Olympus Net Income?

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax. Olympus's Net Income for the three months ended in Dec. 2023 was 円18,916 Mil. Its Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was 円270,427 Mil.

Net Income is linked to the most popular Earnings per Share (Diluted) number. Olympus's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was 円15.80.


Olympus Net Income Historical Data

The historical data trend for Olympus's Net Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Olympus Net Income Chart

Olympus Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,147.00 51,670.00 12,918.00 115,742.00 143,432.00

Olympus Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41,381.00 35,215.00 240,560.00 -24,264.00 18,916.00

Olympus Net Income Calculation

Net Income is the net profit that a company earns after deducting all costs and losses including cost of goods, SGA, DDA, interest expenses, non-recurring items and tax.

Net Income
= Revenue - Cost of Goods Sold - Selling, General, & Admin. Expense - Research & Development - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= EBITDA - Depreciation, Depletion and Amortization - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Operating Income - Interest Expense - Non Operating Income (NRI) - Tax Expense + Others
= Pre-Tax Income - Tax Expense + Others

Olympus's Net Income for the fiscal year that ended in Mar. 2023 is calculated as

Net Income(A: Mar. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=182294+-44304+5623+-181
=143,432

Olympus's Net Income for the quarter that ended in Dec. 2023 is calculated as

Net Income(Q: Dec. 2023 )
= Pre-Tax Income + Tax Provision + Net Income (Discontinued Operations) + Others
=33976+-14997+-63+0
=18,916

Net Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円270,427 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Olympus  (TSE:7733) Net Income Explanation

Net Income is the most widely cited number in reporting a company's profitability. It is linked to the most popular earnings-per-share (EPS) number through:

Olympus's Earnings per Share (Diluted) (EPS) for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

EPS is most useful for companies that have:

A predictable business
Consistent accounting methods
And few restructurings

The dividend paid to preferred stocks needs to be subtracted from the total net income in the calculation of EPS because common stock holders are not entitled to that part of the net income.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred Net Income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Olympus Net Income Related Terms

Thank you for viewing the detailed overview of Olympus's Net Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Olympus (TSE:7733) Business Description

Traded in Other Exchanges
Address
Shinjuku Monolith, 2-3-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo, JPN, 163-0914
Olympus Corp manufactures and sells precision instruments for the healthcare industry. The firm operates in three segments: scientific solutions, imaging, and medical. The scientific solutions segment sells microscopes and other imaging tools to life sciences and industrial customers. The imaging segment sells digital cameras under the Olympus brand. The medical segment supplies medical equipment, including gastrointestinal and surgical endoscopes and endotherapy devices. This segment generates the vast majority of revenue. Sales in Asia and North America contribute the largest proportions of revenue.

Olympus (TSE:7733) Headlines

No Headlines